Immuno-modulator metallo-Peptide reduces inflammatory state in obese zucker fa/fa rats

scientific article

Immuno-modulator metallo-Peptide reduces inflammatory state in obese zucker fa/fa rats is …
instance of (P31):
scholarly articleQ13442814

External links are
P932PMC publication ID4198424
P698PubMed publication ID25324698

P50authorLourdes Rodriguez FragosoQ71892259
P2093author name stringJorge Reyes-Esparza
Francisco García-Vázquez
Antonieta Gómez-Solís
Elizabeth Alvarez-Ayala
P2860cites workFrom observation to experimentation: leptin action in the mediobasal hypothalamusQ24644953
Inflammation and metabolic disordersQ27860923
Obesity is associated with macrophage accumulation in adipose tissueQ27860976
Origin and physiological roles of inflammationQ29614298
Adipose tissue as an endocrine organQ29620407
Metabolic syndrome pandemic.Q30366941
Effect of fructooligosaccharides fraction from Psacalium decompositum on inflammation and dyslipidemia in rats with fructose-induced obesity.Q30746231
Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in miceQ33559605
Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver diseaseQ33580624
Relationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: relevance for cardiovascular risk preventionQ33627732
FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese ratsQ33741191
Fat: a matter of disturbance for the immune system.Q34200814
Monocyte chemoattractant protein 1 in obesity and insulin resistanceQ35163496
Human fatty liver disease: old questions and new insightsQ35588477
Peptides and their potential role in the treatment of diabetes and obesityQ35760298
Leptin, from fat to inflammation: old questions and new insights.Q36005249
Adipose tissue, inflammation, and cardiovascular diseaseQ36125401
Endothelial and erectile dysfunction, diabetes mellitus, and the metabolic syndrome: common pathways and treatments?Q36357659
The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular diseaseQ36380101
Recent advances in the relationship between obesity, inflammation, and insulin resistance.Q36448850
Adipose tissue and adipokines--energy regulation from the human perspective.Q36506049
Effect of obesity reduction on preservation of heart function and attenuation of left ventricular remodeling, oxidative stress and inflammation in obese miceQ36552526
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implicationsQ36617551
Antidiabetic treatment restores adiponectin serum levels and APPL1 expression, but does not improve adiponectin-induced vasodilation and endothelial dysfunction in Zucker diabetic fatty ratsQ36711237
Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart diseaseQ36847941
Non-alcoholic fatty liver disease and the metabolic syndrome: an updateQ37054351
Sitagliptin prevents aggravation of endocrine and exocrine pancreatic damage in the Zucker Diabetic Fatty rat - focus on amelioration of metabolic profile and tissue cytoprotective propertiesQ37720797
Physiological, pathological and potential therapeutic roles of adipokines.Q38007838
Antiapoptotic effect of a novel synthetic peptide from bovine muscle and MPG peptide on H2O2-induced C2C12 cellsQ38995239
Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker ratsQ41853980
Effect of synthetic thymic humoral factor (THF-gamma 2) on T cell activities in immunodeficient ageing miceQ42002571
Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue.Q42271438
Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US.Q42869469
Isolation of bovine thymin: a polypeptide hormone of the thymusQ43735353
Insulin and Obesity in the Zucker Genetically Obese Rat “Fatty”Q43740934
A hypercaloric pellet-diet cycle induces obesity and co-morbidities in Wistar ratsQ46344079
Noradrenaline-mediated inhibition of inflammatory cytokines is altered in macrophages from obese Zucker rats: effect of habitual exerciseQ46438686
Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines tumor necrosis factor-alpha and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cellsQ46707414
Thymopentin and splenopentin as immunomodulators. Current statusQ47933330
Plasma Adiponectin in Patients with Active, Early, and Chronic Rheumatoid Arthritis Who Are Steroid- and Disease-Modifying Antirheumatic Drug-Naive Compared with Patients with Osteoarthritis and ControlsQ56974092
T-ing up inflammation in fatQ58197131
Pharmacological evaluation of the immunomodulatory FL-6 in induced chronic hepatitis in Wistar ratsQ61895681
Immune modulation exerted by thymic humoral factor (THF-gamma 2), on T-cell subsets and IL-2 production of umbilical cord blood lymphocytesQ67296152
Supraphysiological triiodothyronine doses diminish leptin and adiponectin gene expression, but do not alter resistin expression in calorie restricted obese ratsQ84071353
Serum interferon gamma concentration is associated with bone mineral density in overweight boysQ87233760
Cardio-adipose tissue cross-talk: relationship between adiponectin, plasma pro brain natriuretic peptide and incident heart failureQ87661825
P433issue3
P921main subjectobesityQ12174
P304page(s)172-181
P577publication date2014-09-01
P1433published inInternational Journal of Biomedical ScienceQ26842285
P1476titleImmuno-modulator metallo-Peptide reduces inflammatory state in obese zucker fa/fa rats
P478volume10

Search more.